Editorial: Immune response to SARS-CoV-2 and implications for clinical outcome

• Edwin Bölke,
• Martijn van Griensven,
• E. Marion Schneider,
• Johannes C. Fischer,
• Torsten Feldt,
• Verena Keitel,
• Wilfried Budach,
• Jan Haussmann,
• Danny Jazmati,
• Christiane Matuschek

Affiliations

Edwin Bölke

Department of Radiation Oncology, University of Dusseldorf, Dusseldorf, Germany

Martijn van Griensven

Department cBITE, Institute for Technology-Inspired Regenerative Medicine, Martijn van Griensven Maastricht University, MERLN, Maastricht, Netherlands

E. Marion Schneider

Division of Experimental Anesthesiology, University Hospital Ulm, Ulm, Germany

Johannes C. Fischer

Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine-University, Dusseldorf, Germany

Torsten Feldt

Clinic of Gastroenterology, Hepatology and Infectious Diseases University Hospital Dusseldorf, Medical Faculty, Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany

Verena Keitel

Clinic of Gastroenterology, Hepatology and Infectious Diseases University Hospital Dusseldorf, Medical Faculty, Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany

Wilfried Budach

Department of Radiation Oncology, University of Dusseldorf, Dusseldorf, Germany

Jan Haussmann

Department of Radiation Oncology, University of Dusseldorf, Dusseldorf, Germany

Danny Jazmati

Department of Radiation Oncology, University of Dusseldorf, Dusseldorf, Germany

Christiane Matuschek

Department of Radiation Oncology, University of Dusseldorf, Dusseldorf, Germany